retatrutide news recency 3 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS investigation 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”

Participants who started at 1mg and escalated slowly over weeks experienced substantially fewer GI issues than those assigned directly to higher doses

Cai XS, Tan ZG, Li JJ, et al

That said, room temp doesnt mean the inside of your car in July

The medical term for this process is delayed gastric emptying

Cost is also significantly higher , with grey market retatrutide typically running 2-3x the price of compounded tirzepatide

Health-conscious individuals concerned about metabolic health, those with family histories of diabetes or cardiovascular disease, and patients experiencing unexplained fatigue, weight changes, or vision problems should consider this screening (Epicentre 2025)